Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
Investigation of Psychomotor and Cognitive Residual Effects of Single Oral Doses of Zolpidem
Tartrate Extended Release 12.5 mg and Eszopiclone 3 mg Compared to Placebo in Healthy Young
Volunteers, Using Flurazepam 30 mg as an External Comparator